| Ytd | 24.74% | |
| 1y | 8.51% |
| Open | 28.63 | Prev Close | 28.62 | Low | 28.60 | High | 28.63 | Mkt Cap | 2.82B |
| Vol | 20.67K | Avg Vol | 2.17M | EPS | -6.11 | P/E | -4.68 | Forward P/E | 22.32 |
| Beta | 0.31 | Short Ratio | 9.06 | Inst. Own | 101.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 27.26 | 200-d Avg | 27.20 | 1yr Est | 52.53 |
RARE News
Fifth Third Bancorp bought a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) during the f
LEADING EDGE MATERIALS ADVANCES MIDSTREAM PROCESSING STRATEGY FOR THE NORRA KÄRR HEAVY RARE EARTH EL
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims
RBC Capital analyst Luca Issi maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Outperform
U.S. stocks traded higher by midday Wednesday, with semiconductor equipment names and small caps lea
U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a
On Tuesday, 838 companies hit new 52-week lows.
On Friday, 404 stocks made new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear
Stocks That Hit 52-Week Lows On Monday